This article was originally published in The Tan Sheet
FDA Nonprescription Drugs Advisory Committee meeting tentatively scheduled for April 15-16 has been cancelled due to lack of agenda items. Future tentatively scheduled dates include July 19-20, Oct. 18-19 and Dec. 2-3
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC